Healthcare Setting Articles & Analysis
-
HiberGene Diagnostics introduces brand new UK division at NEQAS event
HiberGene Diagnostics, the leading manufacturer of molecular diagnostics products in Ireland, is pleased to announce that it will supply its innovative point-of-care (POC) and near-patient testing solutions directly to healthcare providers in the UK and Ireland. These high-quality testing solutions cover infectious and transmissible disease areas – including respiratory, sexually ...
-
Klebsiella in Healthcare Settings Discussed in New Online Video
The IAQ Video Network and Cochrane & Associates announced the release of their latest educational video today. Their newest production discusses Klebsiella, a type of gram-negative bacteria that can cause various healthcare-associated infections (HAIs). “HAIs due to Klebsiella can include pneumonia, bloodstream infections, wound or surgical site infections, and meningitis,” said ...
-
Midwest Hospitals on the Lookout for MDR-AB
In November of last year, a new study was published in the American Journal of Infection Control (AJIC). It indicated the common presence of Acinetobacter baumannii (MDR-AB), a dangerous multi-drug resistant bacterium, in numerous patient rooms in healthcare settings. Researchers found that MDR-AB was present in the indoor environment of 48% of the rooms of patients infected or colonized by the ...
-
GC-IMS for medical and healthcare applications
Imspex Diagnostics’ proprietary GC-IMS analytical technology platform has built a legacy of being a versatile, accurate and robust analytical research tool in situations where compound combinations are complex and/ or concentrations are low. Much of this legacy has centred around volatile compounds in industrial and more recently environmental and food production settings. The ultra-highly ...
-
Lungpacer Medical, Inc. Announces FDA Approval of Emergency Use Authorization of the Lungpacer Diaphragm Pacing Therapy System to Help Address COVID-19 Pandemic
Lungpacer Medical, Inc., a medical device company developing an intravenous catheter-based phrenic-nerve-pacing system, announced today that the FDA has approved the Emergency Use Authorization for the use of the Lungpacer Diaphragm Pacing Therapy System (DPTS) to assist in weaning patients determined by their healthcare provider to be at high risk of weaning failure. According to the FDA ...
-
World MRSA Awareness Month Discussed in New Online Video
The IAQ Video Network and Cochrane & Associates announced the release of their latest educational video today. Their newest production discusses World MRSA Awareness Month which takes place each October. “Methicillin-resistant Staphylococcus aureus (MRSA) is a type of staph that can be resistant to several antibiotics,” said Paul Cochrane, President of Cochrane & ...
-
Infection Control Resources to Identify Klebsiella and Other Pathogens in Healthcare Settings throughout Puerto Rico
The Centers for Disease Control and Prevention (CDC) describes Klebsiella as a type of gram-negative bacteria that can cause different types of healthcare-associated infections (HAIs). These include pneumonia, bloodstream infections, wound or surgical site infections, and meningitis. The agency warns Klebsiella bacteria have increasingly developed antimicrobial resistance, most recently to the ...
-
MRSA Exposed in New Public Outreach Video
Today the IAQ Video Network released the 14th in a series of public outreach videos meant to educate families about important environmental and indoor air quality issues. The public outreach videos have all been produced in the past year covering everything from mold and Legionella to the latest video about Methicillin-resistant Staphylococcus aureus (MRSA). MRSA, is a type of staph bacteria ...
-
New and huge Al Adan Hospital Includes Cutting Edge Technology from Ecosir Group
After new expansion Al Adan Hospital will be one of the largest in the Middle East area, almost doubling in size to approx. 500.000 m2. The automatic waste and linen transfer system installed is latest healthcare technology from Ecosir Group. Succeeding in an international tender process is a great achievement for us and for Finnish healthcare technology exports, says Ecosir Group’s CEO ...
-
ABBOTT INFORMATICS LAUNCHES STARLIMS PUBLIC HEALTH SOLUTION PH12.0
Hollywood, FL - Abbott Informatics is pleased to announce the launch of the STARLIMS Public Health Solution PH12.0. Abbott Informatics has the STARLIMS Public Health (PH) Solution product currently deployed in laboratories throughout the United States. Nevertheless, enhancements need to continuously be added in order for our product to satisfy evolving market needs. Newborn screening is one such ...
-
Infection Control Resources to Mitigate Patient Exposure Risks to Klebsiella and Other Pathogens
An article published last year in Emerging Infectious Diseases detailed a notable increase of carbapenem-resistant Klebsiella pneumoniae (CRKP) infections in New York City during 2021 through June of 2022. The data for the study came from a large public healthcare system in New York City that serves more than 1.2 million people each year. The Centers for Disease Control and Prevention (CDC) ...
-
Infection Control Resources to Safeguard Patients from Vancomycin-Resistant Enterococci and Other Pathogens
The New York State Department of Health (NYSDOH) describes enterococci as part of the normal flora in the intestinal tract and also a common cause of nosocomial infections. The bacteria can also often found in the natural environment, in soil and water. The Centers for Disease Control and Prevention (CDC) warns these bacteria are constantly finding new ways to avoid the effects of the ...
-
Infection Control Professionals Battle Burkholderia cepacia
Burkholderia cepacia is the name for a group or “complex” of bacteria that can be found in soil and water and survive for extended periods of time in moist environments. Also known as BCC or B. cepacia, the bacteria are often resistant to common antibiotics. Burkholderia cepacia poses little medical risk to most healthy people. However, people who have certain health problems ...
-
Candidiasis Infections Impact Midwest Healthcare Facilities
Candidiasis is caused by fungal pathogens from the Candida genus. Most infections are caused by Candida albicans, a type of fungus that grows both as a yeast and filamentous cells. The ubiquitous fungi represent one of the most common fungal pathogens to affect the human population. According to the Centers for Disease Control and Prevention (CDC), “Invasive candidiasis is a fungal ...
-
Published Research Shows CSA-131’s Potent Efficacy against Global Health Threat
N8 Medical, LLC today announced a peer-reviewed publication in The Journal of Antimicrobial Chemotherapy with U.S. Centers for Disease Control and Prevention (CDC) co-authors of promising efficacy data regarding the activity of ceragenin CSA-131 against 100 strains of Candida auris (C. auris) collected from around the world. C. auris is a highly virulent and lethal pathogen of key clinical ...
-
Environmental Pathogens, Antimicrobial Resistance and the Importance of Surface Disinfection in Healthcare Environments
Antimicrobial resistance (AMR), as defined by the Centers for Disease Control and Prevention (CDC), is the ability of microbes to resist the effects of drugs – that is, the germs are not killed and their growth is not stopped. These pathogens can be found in the environment in the air, water, soil and on surfaces, as well as in or on people and animals. All types of microbes have the ...
-
Mitigating Exposure Risks to Mucormycetes to Protect Patients, Workers, and Building Occupants
Mucormycetes are a group of fungi that can cause a rare but serious fungal infection known as mucormycosis reports the Centers for Disease Control and Prevention (CDC). These fungi live in soil and decaying organic matter. People with a weakened immune system could get mucormycosis by inhaling fungal spores or if they enter the skin through an injury. Types of mucormycosis listed by CDC include: ...
-
Core Helps Prevent Nosocomial Infections
Core, one of the most recognized providers of commercial indoor air quality (IAQ) services, provides testing services to ensure the air in healthcare facilities doesn’t lead to nosocomial infections. There are a reportedly 1.7 million hospital acquired infections diagnosed each year in the United States. A study sponsored by Resources for the Future and reported in a 2006 issue of the ...
-
CDC Awards Millions to Fight Healthcare-Associated Infections
According to the Centers for Disease Control and Prevention (CDC) one out of every twenty hospital patients acquires an infection while being treated for another illness. To help combat this problem, the CDC’s Prevention Epicenter Program recently announced $10 million awarded to five medical centers to explore ways to reduce healthcare-associated infections (HAIs). Also this week the ...
-
New Accelerate Pheno Landmark Study Validates Important Clinical Benefits to Be Presented at ECCMID 2021
In Patients Who Receive Ineffective Empirical Antibiotics for Blood Stream Infections (BSI), Use of AXDX Was Associated With Reduction in 30-Day Mortality Interim Data From Multicenter Study Highlight the Real-World Clinical Utility of Fast Phenotypic Antimicrobial Susceptibility Testing for BSI Across Diverse Healthcare Settings and Patient Populations Accelerate Diagnostics, Inc. ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you